Business Description
C-Rad AB
ISIN : SE0002016352
Share Class Description:
FRA:24C: Shs -B-Total Employee Number:
113Compare
Compare
Traded in other countries / regions
CRAD B.Sweden0R44.UK24C.Germany IPO Date
2021-02-11Description
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 15.19 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.12 | |||||
Interest Coverage | 8.19 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 7.2 | |||||
Beneish M-Score | -2.96 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.6 | |||||
3-Year EBITDA Growth Rate | -5.4 | |||||
3-Year EPS without NRI Growth Rate | 12.1 | |||||
3-Year Book Growth Rate | 13.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 95.02 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 9.2 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.59 | |||||
9-Day RSI | 50.08 | |||||
14-Day RSI | 51.21 | |||||
3-1 Month Momentum % | 44.95 | |||||
6-1 Month Momentum % | 8.97 | |||||
12-1 Month Momentum % | -1.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.34 | |||||
Quick Ratio | 2.95 | |||||
Cash Ratio | 1.05 | |||||
Days Inventory | 150.93 | |||||
Days Sales Outstanding | 140.4 | |||||
Days Payable | 77.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.28 | |||||
Dividend Payout Ratio | 0.07 | |||||
Forward Dividend Yield % | 0.28 | |||||
5-Year Yield-on-Cost % | 0.28 | |||||
3-Year Average Share Buyback Ratio | 0.6 | |||||
Shareholder Yield % | 0.84 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 73.29 | |||||
Operating Margin % | 14.92 | |||||
Net Margin % | 11.23 | |||||
EBITDA Margin % | 17.55 | |||||
FCF Margin % | 6.15 | |||||
OCF Margin % | 6.15 | |||||
ROE % | 14.19 | |||||
ROA % | 10.03 | |||||
ROIC % | 16.64 | |||||
3-Year ROIIC % | 33.26 | |||||
ROC (Joel Greenblatt) % | 59.66 | |||||
ROCE % | 18.22 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 25.55 | |||||
Forward PE Ratio | 15.43 | |||||
PE Ratio without NRI | 25.55 | |||||
Shiller PE Ratio | 74.22 | |||||
Price-to-Owner-Earnings | 38.69 | |||||
PEG Ratio | 3.23 | |||||
PS Ratio | 2.87 | |||||
PB Ratio | 3.41 | |||||
Price-to-Tangible-Book | 3.91 | |||||
Price-to-Free-Cash-Flow | 45.82 | |||||
Price-to-Operating-Cash-Flow | 45.82 | |||||
EV-to-EBIT | 16.48 | |||||
EV-to-Forward-EBIT | 13.69 | |||||
EV-to-EBITDA | 14 | |||||
EV-to-Forward-EBITDA | 11.73 | |||||
EV-to-Revenue | 2.44 | |||||
EV-to-Forward-Revenue | 2.33 | |||||
EV-to-FCF | 39.23 | |||||
Price-to-GF-Value | 1.12 | |||||
Price-to-Projected-FCF | 1.8 | |||||
Price-to-Median-PS-Value | 0.61 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.41 | |||||
Price-to-Graham-Number | 2.11 | |||||
| Price-to-Net-Current-Asset-Value | 4.22 | |||||
Earnings Yield (Greenblatt) % | 6.06 | |||||
FCF Yield % | 2.28 | |||||
Forward Rate of Return (Yacktman) % | 20.3 |
C-Rad AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
C-Rad AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-23 11:00 | In 81 days | ||
| Third quarter earnings results for 2026 | 2026-10-23 08:30 | In 81 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-22 11:00 | In 80 days | ||
| Third quarter earnings results for 2026 | 2026-10-22 08:00 | In 80 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-17 11:00 | 3.27 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-07-17 08:00 | 3.27 (+0.00%) | ||
| General meeting for 2026 | 2026-05-08 15:00 | 2.78 (+0.00%) | ||
| SEK 0.100000 Cash Dividend | 2026-05-08 | 2.78 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 11:00 | 2.98 (+33.04%) | ||
| General meeting for 2026 | 2026-05-07 11:00 | 2.98 (+33.04%) |
Show
Entries
Press Release
Articles on C-Rad AB
No articles.